FindTrial
Sign In

Comparative study for human papilloma virus detection in oral and oropharyngeal carcinomas

Comparative study of Immunoglobulins (IgG and IgM) for human papilloma virus detection from saliva, oral rinse and plasma in oral and oropharyngeal carcinomas

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028543
Enrollment
50
Registered
2020-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

GMCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients coming to the OPD of the Department of Otorhinolaryngology, Head and Neck surgery with lesions suspicious of malignancy in the oral cavity and oropharynx.

Exclusion criteria

Exclusion criteria: 1.Patients giving the history of HPV vaccination. 2.Patients who have already undergone biopsy and their report came as non-descriptive, not requiring repeat biopsy. 3.Patients who are currently undergoing treatment regimens like Chemotherapy, Radiotherapy. 4.Patients who have already undergone definitive or salvage treatment for primary or recurrent oral and oropharyngeal carcinomas.

Design outcomes

Primary

MeasureTime frame
carcinomaTimepoint: more than 2 months from onset of symptoms—

Secondary

MeasureTime frame
mortalityTimepoint: 5 year survival—

Countries

India

Contacts

Public ContactDr Nitin Gupta

Government Medical Collage Hospital

nitinent123@gmail.com9646121704

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026